Microbial assays are a technique to assess a compound’s potency or concentration. This is carried out by exposing microorganisms to the compound and determining its effect on them. Microbial assays ...

The measurement of specific molecules in serum and plasma is essential in the diagnosis, treatment and management of many diseases. Traditional methods have used single assay techniques, whereby only ...

Minimal residual disease (MRD)—minute populations of cancer cells undetectable by conventional imaging—remains the chief ...

Only one out of 10,000 potential chemicals that are evaluated for drug discovery ever reach the market, and 40% of the compounds that begin animal trials will fail due to toxicity. Therefore, ...

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...

The demand for new drugs is pushing companies to develop cell-based assays that focus on a specific cellular event, potentially leading to tailored and more potent therapies. These assays also hold ...

In resource-limited settings, genomic assays for hormone receptor-positive, HER2-negative breast cancer aren't always ...

Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) are found in high global seroprevalence. Infections usually are asymptomatic or manifest as mild or subclinical disease in immunocompetent ...